Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working
Conditions:   Locally Advanced Leiomyosarcoma;   Metastatic Leiomyosarcoma;   Stage III Uterine Corpus Leiomyosarcoma AJCC v8;   Stage IV Uterine Corpus Leiomyosarcoma AJCC v8;   Unresectable Leiomyosarcoma;   Uterine Corpus Leiomyosarcoma Interventions:   Drug: Olaparib;   Drug: Pazopanib;   Drug: Temozolomide;   Drug: Trabectedin Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2022 Category: Research Source Type: clinical trials

Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2
Condition:   Leiomyosarcoma Intervention:   Other: Blood samples will be collected at different times. Sponsors:   Institut Claudius Regaud;   Fondation ARC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2022 Category: Research Source Type: clinical trials